Sabby Management, Llc Buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo Drugstores Inc, Sells Brainstorm Cell Therapeutics Inc, Odonate Therapeutics Inc, Loop Industries Inc

• New Purchases: ATNM, AMPE, CJJD, GNCA, INNT, DFFN, SHIP, 2PU1, AVCO, ALRN, AMRN, STOK, SLS, EMAN, 2QAA, 2RW, BL43, HXB2, TMDI, OPTT, RMTI, AVEO, CALA, ADXS, ALT, RKDA, CLSN, II2Q, AEZS, KTOV, SINT,
• Added Positions: VXRT, OGEN, NURO, SCON, SYN, GNPX, CYTR, SPHS, APOP,
• Reduced Positions: BCLI, ODT, ORMP, UMRX, CODX, ISR, SOLO, OPGN, ABIL, VBLT, AKAOQ, EYEN, 1XS3,
• Sold Out: LOOP, BIIB, FGEN, AQB, NVAX, 9MGM, VTVT, DMPI, HSGX, BLPH, RWLK, CRMD, KPTI, HMTV, CUR, MKGI, FCEL, PTI, BLRX, BLIN,

For the details of SABBY MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/sabby+management%2C+llc/current-portfolio/portfolio

1. Odonate Therapeutics Inc (ODT) - 133,105 shares, 14.48% of the total portfolio. Shares reduced by 43.05%
2. Actinium Pharmaceuticals Inc (ATNM) - 8,343,716 shares, 6.09% of the total portfolio. New Position
3. Ampio Pharmaceuticals Inc (AMPE) - 5,265,265 shares, 6.05% of the total portfolio. New Position
4. China Jo-Jo Drugstores Inc (CJJD) - 1,827,203 shares, 5.96% of the total portfolio. New Position
5. Genocea Biosciences Inc (GNCA) - 494,175 shares, 5.74% of the total portfolio. New Position

Sabby Management, Llc initiated holding in Actinium Pharmaceuticals Inc. The purchase prices were between $0.24 and $0.6, with an estimated average price of $0.33. The stock is now traded at around $0.22. The impact to a portfolio due to this purchase was 6.09%. The holding were 8,343,716 shares as of .

Sabby Management, Llc initiated holding in Ampio Pharmaceuticals Inc. The purchase prices were between $0.39 and $0.7, with an estimated average price of $0.53. The stock is now traded at around $0.42. The impact to a portfolio due to this purchase was 6.05%. The holding were 5,265,265 shares as of .

Sabby Management, Llc initiated holding in China Jo-Jo Drugstores Inc. The purchase prices were between $1.01 and $3.22, with an estimated average price of $1.41. The stock is now traded at around $1.07. The impact to a portfolio due to this purchase was 5.96%. The holding were 1,827,203 shares as of .

Sabby Management, Llc initiated holding in Genocea Biosciences Inc. The purchase prices were between $3.47 and $6.71, with an estimated average price of $5.21. The stock is now traded at around $3.03. The impact to a portfolio due to this purchase was 5.74%. The holding were 494,175 shares as of .

Sabby Management, Llc initiated holding in Innovate Biopharmaceuticals Inc. The purchase prices were between $1.07 and $2.04, with an estimated average price of $1.5. The stock is now traded at around $0.88. The impact to a portfolio due to this purchase was 4.59%. The holding were 1,336,248 shares as of .

Sabby Management, Llc initiated holding in Diffusion Pharmaceuticals Inc. The purchase prices were between $2.76 and $5.9, with an estimated average price of $3.59. The stock is now traded at around $2.04. The impact to a portfolio due to this purchase was 3.96%. The holding were 468,620 shares as of .

Sabby Management, Llc added to a holding in Vaxart Inc by 367.33%. The purchase prices were between $0.63 and $2.04, with an estimated average price of $0.83. The stock is now traded at around $0.66. The impact to a portfolio due to this purchase was 1.44%. The holding were 920,647 shares as of .

Sabby Management, Llc added to a holding in Oragenics Inc by 146.60%. The purchase prices were between $0.46 and $0.6, with an estimated average price of $0.51. The stock is now traded at around $0.40. The impact to a portfolio due to this purchase was 1.09%. The holding were 1,259,333 shares as of .

Sabby Management, Llc added to a holding in NeuroMetrix Inc by 163.24%. The purchase prices were between $0.4 and $1.08, with an estimated average price of $0.73. The stock is now traded at around $0.35. The impact to a portfolio due to this purchase was 0.61%. The holding were 809,482 shares as of .

Sabby Management, Llc added to a holding in Superconductor Technologies Inc by 78.95%. The purchase prices were between $0.71 and $1.71, with an estimated average price of $1.23. The stock is now traded at around $0.74. The impact to a portfolio due to this purchase was 0.5%. The holding were 467,900 shares as of .

Sabby Management, Llc added to a holding in Synthetic Biologics Inc by 31.95%. The purchase prices were between $0.49 and $0.66, with an estimated average price of $0.58. The stock is now traded at around $0.43. The impact to a portfolio due to this purchase was 0.36%. The holding were 903,741 shares as of .

Sabby Management, Llc added to a holding in Sophiris Bio Inc by 56.60%. The purchase prices were between $0.71 and $1.1, with an estimated average price of $0.88. The stock is now traded at around $1.00. The impact to a portfolio due to this purchase was 0.05%. The holding were 52,685 shares as of .

Sabby Management, Llc sold out a holding in Loop Industries Inc. The sale prices were between $6.63 and $9.99, with an estimated average price of $7.78.

Sabby Management, Llc sold out a holding in Biogen Inc. The sale prices were between $219.29 and $241.72, with an estimated average price of $230.78.

Sabby Management, Llc sold out a holding in FibroGen Inc. The sale prices were between $35.13 and $55.53, with an estimated average price of $43.71.

Sabby Management, Llc sold out a holding in AquaBounty Technologies Inc. The sale prices were between $1.96 and $3.21, with an estimated average price of $2.35.

Sabby Management, Llc sold out a holding in Novavax Inc. The sale prices were between $4.93 and $12.24, with an estimated average price of $7.88.

Sabby Management, Llc sold out a holding in Taronis Technologies Inc. The sale prices were between $0.14 and $0.83, with an estimated average price of $0.45.